Search for Clinical Trial Results

Erythema Multiforme - 15 Studies Found
Status | Study |
Completed |
Study Name: Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05% Condition: Plaque Psoriasis Date: 2013-06-26 Interventions: Drug: Clobex Spray Other Name: Clobetasol propionate spray |
Recruiting |
Study Name: A Randomized Two Arm Phase II Trial of Pembrolizumab Alone or Sequentially Following Single Fraction Non-ablative Radiation to One of the Target Lesions, in Previously Treated Patients With Stage IV NSCLC Condition: Stage IV Non-Small Cell Lung Cancer Date: 2016-01-14 Interventions:
|
Not yet recruiting |
Study Name: Discerning Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Guided Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy Condition:
|
Completed |
Study Name: Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer Condition: Head and Neck Cancer Date: 2001-08-10 Interventions: Drug: liposomal lurtotecan |
Active, not recruiting |
Study Name: Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae) Condition:
|
Recruiting |
Study Name: HLA-B*5801 Screening to Prevent Allopurinol-induced Severe Cutaneous Adverse Reaction Condition:
Date: 2017-02-06 Interventions: Genetic: HLA-B*5801 test Check whether a participant has HLA-B*5801 allele or not, before administration |
Not yet recruiting |
Study Name: Cyclosporine and Etanercept in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Condition:
Date: 2016-11-25 Interventions:
|
Completed |
Study Name: Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids. Condition:
Date: 2012-09-20 Interventions: Drug: Intravenous immunoglobulin |
Completed |
Study Name: Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye Condition: Stevens-Johnson Syndrome Date: 2010-11-08 Interventions: Drug: 0.05%cyclosporin eye drop use twice daily for 6 months |
Withdrawn |
Study Name: Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) Condition:
Date: 2010-11-19 Interventions: Drug: Infliximab The drug will be administered intravenously every month for 110 weeks (duration of the |